Market Cap 227.08B
Revenue (ttm) 41.95B
Net Income (ttm) 13.40B
EPS (ttm) N/A
PE Ratio 25.90
Forward PE 25.10
Profit Margin 31.95%
Debt to Equity Ratio 0.25
Volume 6,998,900
Avg Vol 5,954,480
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 95%
Beta 0.68
Analysts Strong Sell
Price Target $146.29

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement th...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, North Chicago, United States
HedgeAlerts
HedgeAlerts Nov. 15 at 11:20 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ABT $130.00 Put · NOV 21, 2025 Exp Entry Price: $1.22 - $1.27 Exit Price Target: $2.01 Profit Margin: +58% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
WayneSmith
WayneSmith Nov. 15 at 10:54 PM
$ABT $LIN $CAT $RTX Active trading
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 9:58 PM
$ABT: The last close at $130.59 indicates a position near the 60D high of $137.49, suggesting a potential resistance level. The RSI at 61.78 indicates bullish momentum but is approaching overbought territory, which may limit upside potential. The MA30 at $128.3 is below the current price, providing a support level, while the MA50 at $130.38 is close to the last close, indicating a mixed short-term trend. Directional bias leans slightly bullish due to the price being above both MAs, but caution is warranted given the proximity to the 60D high. Suggested entry: $130.00 (slightly below the last close for better positioning). Stop: $128.00 (below MA30 for risk management). Targets: $135.00 (first target near resistance) and $137.00 (second target at 60D high). Monitor RSI for potential reversal signals. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 7:56 AM
$ABT: The last close at $130.59 indicates a position near the 60D high of $137.49, suggesting a potential resistance level. The RSI at 61.78 indicates bullish momentum but is approaching overbought territory, which may limit upside potential. The MA30 at $128.3 is below the current price, providing a support level, while the MA50 at $130.38 is close to the last close, indicating a mixed short-term trend. Directional bias leans slightly bullish due to the price being above both MAs, but caution is warranted given the proximity to the 60D high. Suggested entry: $130.00 (slightly below the last close for better positioning). Stop: $128.00 (below MA30 for risk management). Targets: $135.00 (first target near resistance) and $137.00 (second target at 60D high). Monitor RSI for potential reversal signals. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:17 PM
$ABT is currently trading at $130.59, above the 30-day moving average (MA30) of $128.3 and slightly above the 50-day moving average (MA50) of $130.38, indicating a bullish trend. The RSI of 61.78 suggests the stock is nearing overbought territory but still has room to run. The recent 60-day high of $137.49 provides a potential target, while the 60-day low of $122.44 establishes a support level. Directional bias is bullish, supported by the stock's position relative to key moving averages and the RSI indicating strength without being excessively overbought. Suggested entry point is at $131.00, with a stop loss set at $128.00 to manage risk. Target 1 is set at $135.00, aligning with a resistance level, and Target 2 at $137.00, near the recent high. Monitor market conditions and adjust the plan as necessary. https://privateprofiteers.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:03 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ABT $130.00 Put · NOV 21, 2025 Exp Entry Price: $1.71 - $1.82 Exit Price Target: $3.49 Profit Margin: +104% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 14 at 12:47 PM
$ABT RSI: 58.95, MACD: -0.7447 Vol: 1.78, MA20: 126.48, MA50: 130.10 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
_Verticality
_Verticality Nov. 14 at 10:34 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $MDT $ABT $CNQ $L l
0 · Reply
_Verticality
_Verticality Nov. 14 at 8:48 AM
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 8:23 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ABT $129.00 Put · NOV 21, 2025 Exp Entry Price: $1.59 - $1.60 Exit Price Target: $3.22 Profit Margin: +101% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Latest News on ABT
10 Defensive Stocks with Market-Beating Yields

Nov 8, 2025, 1:10 PM EST - 7 days ago

10 Defensive Stocks with Market-Beating Yields

DG


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 14 days ago

Best Dividend Aristocrats For November 2025

ABBV ADM ADP AMCR AOS ATO BDX


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 17 days ago

Best Dividend Kings: October 2025

ABBV ABM ADM ADP AWR BDX BKH


Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming

Oct 18, 2025, 9:39 AM EDT - 4 weeks ago

Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming


Gold Gains Over 1%; Abbott Shares Fall After Q3 Results

Oct 15, 2025, 2:20 PM EDT - 4 weeks ago

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results


Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript

Oct 15, 2025, 1:36 PM EDT - 4 weeks ago

Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript


Abbott Labs Posts Higher Sales, Reaffirms Outlook

Oct 15, 2025, 7:55 AM EDT - 4 weeks ago

Abbott Labs Posts Higher Sales, Reaffirms Outlook


Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 7 weeks ago

Best Dividend Aristocrats For October 2025

ADP ATO BDX BEN CAH CHRW CL


Abbott Hosts Conference Call for Third-Quarter Earnings

Sep 24, 2025, 9:00 AM EDT - 7 weeks ago

Abbott Hosts Conference Call for Third-Quarter Earnings


Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

Sep 19, 2025, 2:25 PM EDT - 2 months ago

Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

GE KR PM


1 Dividend King To Hold And 2 Worth Buying Now

Sep 19, 2025, 12:37 PM EDT - 2 months ago

1 Dividend King To Hold And 2 Worth Buying Now

FRT PPG


Abbott Declares 407th Consecutive Quarterly Dividend

Sep 19, 2025, 9:00 AM EDT - 2 months ago

Abbott Declares 407th Consecutive Quarterly Dividend


Inside Abbott's big bet on the future of healthcare

Sep 6, 2025, 9:01 AM EDT - 2 months ago

Inside Abbott's big bet on the future of healthcare


Abbott CEO reveals the biggest disruptions in healthcare

Aug 27, 2025, 2:30 PM EDT - 2 months ago

Abbott CEO reveals the biggest disruptions in healthcare


Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 2 months ago

Best Dividend Aristocrats For September 2025

ABBV ADM ADP AFL ALB AMCR AOS


Best Dividend Kings: August 2025

Aug 24, 2025, 10:13 PM EDT - 2 months ago

Best Dividend Kings: August 2025

ABBV ABM ADM AWR BDX BKH CINF


Abbott India's profit climbs on healthy pharmaceutical demand

Aug 12, 2025, 4:18 AM EDT - 3 months ago

Abbott India's profit climbs on healthy pharmaceutical demand


Abbott Laboratories Q2 Earnings: Dividends Don't Lie

Aug 9, 2025, 8:47 AM EDT - 3 months ago

Abbott Laboratories Q2 Earnings: Dividends Don't Lie


Best Dividend Aristocrats For August 2025

Jul 28, 2025, 5:19 AM EDT - 3 months ago

Best Dividend Aristocrats For August 2025

BDX BEN


Best Dividend Kings: July 2025

Jul 22, 2025, 9:31 AM EDT - 4 months ago

Best Dividend Kings: July 2025

ABBV ABM ADM ADP AWR BDX BKH


Abbott Laboratories: What's Behind The Q2 Earnings Slump?

Jul 18, 2025, 8:51 AM EDT - 4 months ago

Abbott Laboratories: What's Behind The Q2 Earnings Slump?


Abbott CEO Robert Ford goes one-on-one with Jim Cramer

Jul 17, 2025, 7:56 PM EDT - 4 months ago

Abbott CEO Robert Ford goes one-on-one with Jim Cramer


Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript

Jul 17, 2025, 2:05 PM EDT - 4 months ago

Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript


Abbott Reports Second-Quarter 2025 Results

Jul 17, 2025, 7:30 AM EDT - 4 months ago

Abbott Reports Second-Quarter 2025 Results


HedgeAlerts
HedgeAlerts Nov. 15 at 11:20 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ABT $130.00 Put · NOV 21, 2025 Exp Entry Price: $1.22 - $1.27 Exit Price Target: $2.01 Profit Margin: +58% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
WayneSmith
WayneSmith Nov. 15 at 10:54 PM
$ABT $LIN $CAT $RTX Active trading
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 9:58 PM
$ABT: The last close at $130.59 indicates a position near the 60D high of $137.49, suggesting a potential resistance level. The RSI at 61.78 indicates bullish momentum but is approaching overbought territory, which may limit upside potential. The MA30 at $128.3 is below the current price, providing a support level, while the MA50 at $130.38 is close to the last close, indicating a mixed short-term trend. Directional bias leans slightly bullish due to the price being above both MAs, but caution is warranted given the proximity to the 60D high. Suggested entry: $130.00 (slightly below the last close for better positioning). Stop: $128.00 (below MA30 for risk management). Targets: $135.00 (first target near resistance) and $137.00 (second target at 60D high). Monitor RSI for potential reversal signals. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 7:56 AM
$ABT: The last close at $130.59 indicates a position near the 60D high of $137.49, suggesting a potential resistance level. The RSI at 61.78 indicates bullish momentum but is approaching overbought territory, which may limit upside potential. The MA30 at $128.3 is below the current price, providing a support level, while the MA50 at $130.38 is close to the last close, indicating a mixed short-term trend. Directional bias leans slightly bullish due to the price being above both MAs, but caution is warranted given the proximity to the 60D high. Suggested entry: $130.00 (slightly below the last close for better positioning). Stop: $128.00 (below MA30 for risk management). Targets: $135.00 (first target near resistance) and $137.00 (second target at 60D high). Monitor RSI for potential reversal signals. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:17 PM
$ABT is currently trading at $130.59, above the 30-day moving average (MA30) of $128.3 and slightly above the 50-day moving average (MA50) of $130.38, indicating a bullish trend. The RSI of 61.78 suggests the stock is nearing overbought territory but still has room to run. The recent 60-day high of $137.49 provides a potential target, while the 60-day low of $122.44 establishes a support level. Directional bias is bullish, supported by the stock's position relative to key moving averages and the RSI indicating strength without being excessively overbought. Suggested entry point is at $131.00, with a stop loss set at $128.00 to manage risk. Target 1 is set at $135.00, aligning with a resistance level, and Target 2 at $137.00, near the recent high. Monitor market conditions and adjust the plan as necessary. https://privateprofiteers.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:03 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ABT $130.00 Put · NOV 21, 2025 Exp Entry Price: $1.71 - $1.82 Exit Price Target: $3.49 Profit Margin: +104% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 14 at 12:47 PM
$ABT RSI: 58.95, MACD: -0.7447 Vol: 1.78, MA20: 126.48, MA50: 130.10 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
_Verticality
_Verticality Nov. 14 at 10:34 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $MDT $ABT $CNQ $L l
0 · Reply
_Verticality
_Verticality Nov. 14 at 8:48 AM
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 8:23 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ABT $129.00 Put · NOV 21, 2025 Exp Entry Price: $1.59 - $1.60 Exit Price Target: $3.22 Profit Margin: +101% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 2:51 AM
$ABT: The last close at $129.26 indicates a position above the 30-day moving average (MA30) of $128.43, suggesting bullish momentum. The RSI at 58.95 is approaching overbought territory but still indicates strength, supporting a positive directional bias. The price is also near the midpoint of the 60-day high ($137.49) and low ($122.44), providing a favorable range for potential upward movement. Suggested entry: $129.50, just above the last close to confirm strength. Stop loss: $127.50, below the MA30 for risk management. Targets: First target at $135.00 (near the 60D high), and a second target at $137.00, allowing for potential continuation if momentum persists. Overall, the analysis indicates a bullish outlook with the current price action and indicators supporting upward movement. https://privateprofiteers.com
0 · Reply
EquityClock
EquityClock Nov. 14 at 2:40 AM
Shares of Abbott have been consolidating all year between $120 and $138, but, with the period of seasonal strength for the stock upon us, this may be the opportunity for the stock to thrive. Between November 14th and February 15th, $ABT has averaged returns of 1.68% above the performance of the S&P 500 Total Return index. $XLV
0 · Reply
BMWLTWM3
BMWLTWM3 Nov. 13 at 11:31 PM
$ABT Abbott needs to purchase Senseonics; they akready own 2 m shares; but the whole co....!!
0 · Reply
minter66
minter66 Nov. 13 at 9:58 PM
$ABT It always amazes me that when the market just takes it up the rear on red days, this thing is always green.
0 · Reply
OptionSamurai
OptionSamurai Nov. 13 at 3:59 PM
$ABT appears in our scan that looks for calls that will explode if the stock goes to analyst target. ✔ Analysts rating is BUY ✔ The analyst target price is 12.5% away ✔ IV Percentile is 56.2% Call 135.0, 16-Jan-26 has: 💀 Max loss of 1.7% compared to holding shares ⚖ Breakeven is 6.5% away 📈 If the stock hits the target, the call will profit 356% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 12:56 AM
$ABT: The current market context shows a last close of $127.07, with an RSI of 46.7 indicating neutral momentum. The price is below both the 30-day moving average (MA30) of $128.71 and the 50-day moving average (MA50) of $130.57, suggesting a bearish bias in the short to medium term. The recent high of $137.49 and low of $122.44 over the last 60 days provides a range for potential movement. Suggested entry is at $126.50, slightly below the current price to capture potential downside. Set a stop loss at $124.50 to manage risk. Target 1 is $130.00, near the MA50, and Target 2 is $132.00, aligning with previous resistance levels. This plan leverages the current price position relative to moving averages and the established high-low range, aiming to capitalize on a potential rebound or continued downward movement. https://privateprofiteers.com
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 12 at 8:08 PM
🎯 Target Hit 🏁 📨 From Oct 30, 2025 🏛️ $ABT 💵 Entry: $125.0600 ✅ Exit: $128.4241 💰 P/L: +2.69% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:32 AM
$ABT: The current market context shows a last close of $127.07, with an RSI of 46.7 indicating neutral momentum. The price is below both the 30-day moving average (MA30) of $128.71 and the 50-day moving average (MA50) of $130.57, suggesting a bearish bias in the short to medium term. The recent high of $137.49 and low of $122.44 over the last 60 days provides a range for potential movement. Suggested entry is at $126.50, slightly below the current price to capture potential downside. Set a stop loss at $124.50 to manage risk. Target 1 is $130.00, near the MA50, and Target 2 is $132.00, aligning with previous resistance levels. This plan leverages the current price position relative to moving averages and the established high-low range, aiming to capitalize on a potential rebound or continued downward movement. https://privateprofiteers.com
0 · Reply
Punpire
Punpire Nov. 11 at 11:24 PM
$SENS Sugar MD did an explanation of the Eversense 365 compared to $DXCM and $ABT Libre CGM's last month. If Abbott doesn't buy them out, it's only a matter of time before the Eversense takes over. No Errors, No Failures, No painful sites, No bloody band-aids, No Blood stained white shirts, We're still a few months away from really taking off IMO. If you're thinking about investing in SENS, wait until the Ascensia deal is done (End of the Year) and the Twiist pump actually works.
2 · Reply
jameslee09
jameslee09 Nov. 11 at 6:41 PM
$ABT or DXCM should buy out SENS while still bargain price
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 4:48 PM
0 · Reply
MetaeB
MetaeB Nov. 10 at 7:45 PM
$ABT this stock loves $125 level 😂
0 · Reply